Skip to content
Search for:
Home
About
Leadership Team
Board of Directors
Investors
Pipeline
Science
Newsroom
Contact
archives
jadvargas
2022-04-11T12:59:05-07:00
Cleave Selected Press Releases Archive
<<< Back to Newsroom
Year
Press Release
2016
Cleave Biosciences Raises $37 Million Series B Financing
2015
Cleave Biosciences Granted Key U.S. Patent Covering CB-5083
Cleave Biosciences Receives Orphan Designation from FDA for CB-5083 for Treatment of Multiple Myeloma
2014
Cleave Biosciences Initiates Phase 1 Clinical Trial of CB-5083 in Patients with Multiple Myeloma
Cleave Biosciences Initiates Phase 1 Clinical Trial of CB-5083 in Patients with Advanced Solid Tumors
2013
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
2011
Cleave Biosciences Raises Additional $2 Million in Series A Financing
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Page load link
Go to Top